Connect with us

Hi, what are you looking for?

Jewish Business News

IPOs

David Bonderman Admits To Contemplating Taking TPG Capital Public

Bonderman, co-founder of TPG  formally known as the , hinted during an interview at the SuperReturn International conference in Berlin that an IPO could well be in the offing.

– 

 David Bonderman / Getty

David Bonderman, the co-founder of the private equity firm TPG Capital, was unusually candid during an interview that he gave while attending SuperReturn International, the private equity gathering in Berlin. During the course of the interview, Bonderman, either by accident or by design let it leak that he is considering putting  together an Initial Public Offering (IPO)  for TPG.

If it does come to pass , then the reverberations are bound  to be felt in the market, with TPG and its various affiliate companies controlling around $52 billion in assets under management, while the companies that comprise the TPG portfolio, bringing in annual incomes in excess of $100 billion,  employ a staff in excess of 600, 000 people spread out over n more than 100 countries.

During the course of the interview David Bonderman  hastened  to point out that the majority of TPG’s private equity rivals such as Kohlberg Kravis Roberts (KKR), Apollo Global Management, the Carlyle Group and the Blackstone Group and have all issued  shares in the stock market in recent years, going on to add meaning of these companies had held back in the misplaced fear that they would experience  difficultly balancing the needs to generate long-term returns for their so-called limited partner investors while keeping pace with with the demands of their shareholders shareholders for strong quarterly performance.

Most of these companies now realise that their concern that pension funds and other investments, known in the industry as limited partners, would be less inclined to invest in publicly traded private equity firms. A situation which has not transpired according to. Bonderman who stated that the limited partners have had to learn to “ put their money where their mouth is.”

One of the most respected the gurus in the private equity world, Bonderman is reported as having current  net worth of around  $2.6 billion

 

David Bonderman was a Phi Beta Kappa graduate of the University of Washington in 1963 going on to study at Harvard Law School, where he graduated magna cum laude in 1966.

Shortly after graduating from Harvard, Bonderman took a form of sabbatical, setting up home in Cairo, Egypt, to pursue his dream to study Islamic Legal Jurisprudence and Law. The young Bonderman became especially proficient in various Islamic legal cliques,  in the process developing a near-native fluency in Modern Standard Arabic.

Later in his career, Bonderman initiated the Bonderman Fellows program at his seat of learning, the University of Washington, provided undergraduate and graduate students with opportunities for unstructured international travel and study.

David Bonderman  began his professional career as a Fellow in Foreign and Comparative Law at Harvard University, where he acted as  David Bonderman  special assistant to the U.S. Attorney General later going on to become assistant professor at Tulane University Law School, from 1967 to 1968, going on to take up the post of Fellow in Foreign and Comparative Law in conjunction with Harvard University during the years 1969 to 1970, also acting as Special Assistant to the U.S. Attorney General particularly in the Civil Rights Division.

After entering into the private sector, Mr. Bonderman rose to the position of partner in the law firm of Arnold & Porter in Washington, D.C., specializing in corporate, securities, bankruptcy and antitrust litigation, before leaving to become Chief Operating Officer of the Robert M. Bass Group, Inc. in Fort Worth, Texas.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis cialis satış